序号 | 英文主题词 | 中文主题词 | 命中文献数量(篇) |
---|
期刊 | 博硕士论文 | 会议论文 | 报纸 | 年鉴 | 成果 | 专利 | 国家标准 | 行业标准 | 标准 | 总计 | 121 | 4-Quinolones | 4-喹诺酮类 | 193 | 6 | 11 | 10 | 0 | 1 | 0 | 0 | 0 | 0 | 221 | 122 | 46, XX Disorders of Sex Development | 46, XX性发育障碍 | 1124 | 39 | 94 | 16 | 2 | 4 | 2 | 0 | 0 | 0 | 1281 | 123 | 46, XX Testicular Disorders of Sex Development | 46, XX性发育睾丸疾病 | 17 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 124 | 46, XY Disorders of Sex Development | 46, XY性发育障碍 | 805 | 9 | 78 | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 903 | 125 | 5´ Flanking Region | 5´旁侧区 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 126 | 5´ Untranslated Regions | 5´非翻译区 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127 | 5´-Nucleotidase | 5´-核苷酸酶 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 128 | 5,10-Methylenetetrahydrofolate Reductase (FADH2) | 5,10-亚甲基四氢叶酸还原酶(FADH2) | 35 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 129 | 5,6-Dihydroxytryptamine | 5,6-二羟色胺 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 130 | 5,7-Dihydroxytryptamine | 5,7-二羟色胺 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 131 | 5,8,11,14-Eicosatetraynoic Acid | 5,8,11,14-花生四烯酸 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 132 | 5-alpha Reductase Inhibitors | 5-α还原酶抑制剂 | 199 | 1 | 29 | 40 | 2 | 5 | 6 | 0 | 0 | 0 | 282 | 133 | 5-alpha-Dihydroprogesterone | 5-α-二氢孕酮 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 134 | 5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole | 5-氨基-3-((5-硝基-2-呋喃基)乙烯基)-1,2,4-恶二唑 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135 | 5-Aminolevulinate Synthetase | 5-氨基酮戊酸合成酶 | 5 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 136 | 5-Hydroxytryptophan | 5-羟色氨酸 | 3552 | 131 | 172 | 111 | 9 | 21 | 28 | 0 | 0 | 0 | 4024 | 137 | 5-Lipoxygenase-Activating Protein Inhibitors | 5-脂氧合酶-激活蛋白抑制剂 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 138 | 5-Lipoxygenase-Activating Proteins | 5-脂氧合酶-激活蛋白 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 139 | 5-Methoxytryptamine | 5-甲氧色胺 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 140 | 5-Methylcytosine | 5-甲基胞嘧啶 | 25 | 2 | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 33 |
|
|